ArticleBMC research notes2026
Antibacterial and wound healing activities of AgNPs, ZnONPs, and Fe
Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aimed to evaluate the individual and combined effects of silver nanoparticles (AgNPs), zinc oxide nanoparticles (ZnO-NPs), and iron oxide nanoparticles (Fe₃O₄-NPs) on wound healing in a rat model of infection with Acinetobacter baumannii and Escherichia coli, and to compare their efficacy with a standard antibiotic treatment.
resultsAgNPs demonstrated the strongest antibacterial growth inhibition in vitro, while ZnO-NPs showed limited antibacterial activity under the tested conditions. Combination assays indicated enhanced bacterial growth inhibition for AgNP + Fe₃O₄-NPs, whereas ZnO-NPs did not increase antibacterial inhibition in vitro. Nanoparticle-treated wounds showed faster healing than controls in rat models infected with E. coli and A. baumannii. Complete wound closure by day nine was observed in the Ag + ZnO and Fe₃O₄ groups for E. coli infection and in the Ag, ZnO, and Ag + ZnO groups for A. baumannii. Wound-healing rates reached 100% in the Fe₃O₄ and Ag + ZnO groups, which was significantly higher than in untreated controls. Histological evaluation revealed no necrosis in any group, while treated wounds exhibited increased granulation tissue formation and reduced inflammation. Overall, the Ag + ZnO nanoparticle combination showed a synergistic effect, leading to superior antibacterial activity and accelerated wound repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.